Original language | English |
---|---|
Pages (from-to) | 595S |
Journal | Journal of Clinical Oncology |
Volume | 22 (14) |
Publication status | Published - 1 Jan 2007 |
Tolerability and efficacy of classical CMF (cCMF) using oral cyclophosphamide (OC) vs intravenous cyclophosphamise (IVC) in early stage breast cancer: A non-randomised comparison of patients (pts) treated in the National Epirubicin Adjuvant Trial (NEAT) 40th Annual American Society of Slinical Oncology meeting. New Orleans, Louisiana USA June 2004
DW Hiller, L Earl, HM Dunn, Sarah Bathers, David Spooner, R Grieve, RK Agrawal
Research output: Contribution to journal › Article